2022
DOI: 10.1016/j.jbc.2022.102347
|View full text |Cite
|
Sign up to set email alerts
|

Human CIDEC transgene improves lipid metabolism and protects against high-fat diet–induced glucose intolerance in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(3 citation statements)
references
References 66 publications
0
3
0
Order By: Relevance
“…Similarly, a transgenic mouse model, in which human FSP27 was overexpressed in the adipose tissue, protected against high‐fat diet‐induced glucose intolerance and lowered levels of triglycerides, cholesterol, and low‐density lipoproteins compared to their littermate controls when fed a high‐fat diet. This suggests that Fsp27 is a potential druggable target to reverse obesity‐induced lipotoxicity and glucose intolerance 101 . Interfering with the expression or function of lipid droplet‐associated perilipins that affect the biogenesis of lipid droplets and various aspects of lipid homeostasis may offer additional viable targets for intervention in the pathogenesis of MASLD.…”
Section: Potential Therapeutic Implicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…Similarly, a transgenic mouse model, in which human FSP27 was overexpressed in the adipose tissue, protected against high‐fat diet‐induced glucose intolerance and lowered levels of triglycerides, cholesterol, and low‐density lipoproteins compared to their littermate controls when fed a high‐fat diet. This suggests that Fsp27 is a potential druggable target to reverse obesity‐induced lipotoxicity and glucose intolerance 101 . Interfering with the expression or function of lipid droplet‐associated perilipins that affect the biogenesis of lipid droplets and various aspects of lipid homeostasis may offer additional viable targets for intervention in the pathogenesis of MASLD.…”
Section: Potential Therapeutic Implicationsmentioning
confidence: 99%
“…This suggests that Fsp27 is a potential druggable target to reverse obesity-induced lipotoxicity and glucose intolerance. 101 Interfering with the expression or function of lipid droplet-associated perilipins that affect the biogenesis of lipid droplets and various aspects of lipid homeostasis may offer additional viable targets for intervention in the pathogenesis of MASLD.…”
Section: Potential Therapeutic Implicationsmentioning
confidence: 99%
“…Fibrates [ 128 ], Niacin [ 129 ] and Fish oil [ 126 , 130 , 131 ], The development of alternatives to statins, which include Evinacumab, the angiotensin-like 2 monoclonal antibody [ 132 ], which has shown adequate safety in trials [ 133 ]. The resurgence of approval for monoclonal antibody treatments for rare disorders [ 134 ] and gene therapy in animal models [ 135 ] will set the direction for the advancement of therapeutics for the management of this emerging disorder.…”
Section: Familial Hypertriglyceridemiamentioning
confidence: 99%